Condition: Rheumatologic Disease · Autoimmune Diseases · Sponsor: University of Alabama at Birmingham
The overall goal of this study is to determine whether a novel, multi-modal, patient-directed behavioral intervention initiated in rheumatology clinics is an effective approach to improve uptake of updated COVID-19 vaccine.
This description comes directly from the study's public registry record.
Mary A Wilkenson, Clinical Research Coordinator, BS · 205-996-7875 · mawilkenson@uabmc.edu
Paolo Rusconi, Project Director, PhD · paolorusconi@uabmc.edu
Always discuss trial participation with your own doctor first.
| University of Alabama at Birmingham | Birmingham, Alabama, United States | Recruiting |
| Brigham Women's Hospital | Boston, Massachusetts, United States | Not Yet Recruiting |
| University of Massachusetts Chan Medical School | Worcester, Massachusetts, United States | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06469788